Table 1

Origin of samples

CentreSettingNMONMOSDControl
Odense, DenmarkMS Clinic, Department of Neurology, Odense University Hospital700
Lyon, FranceDepartment of Neurology A, Lyon University Hospital9615
Munich, GermanyMS Clinic, Klinikum rechts der Isar der TU München, Klinik für Neurologie,628
Pécs, HungaryClinical and Experimental Neuroimmunology Division, Department of Neurology, University of Pécs771
Rotterdam, NetherlandsMS Clinic, MS Centre ErasMS, Erasmus MC, Rotterdam995
Oxford, UKNHS National Specialised Services for Neuromyelitis Optica51714
Berlin, Germany*NeuroCure Clinical Research Center (NCRC), Charité Universitätsmedizin Berlin224
Düsseldorf, Germany*Department of Neurology, Medical Faculty, Heinrich–Heine–University Düsseldorf0039
Heidelberg, Germany*Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Germany664
Bergen, Norway*Department of Neurology, Haukeland University Hospital012
Total515092
  • Coded serum or plasma samples were submitted from 10 centres.

  • *Four centres submitted samples only and did not perform assays.

  • NMO, neuromyelitis optica; NMOSD, NMO spectrum disorder.